Cattran, Charles


Dr. Charles Cattran is an active member of Attending Staff in the Division of Cardiac Anesthesiology and a consultant in the Cardiac Surgery Intensive Care Unit at the University of Ottawa Heart Institute.

He is also Assistant Professor of Clinical Anesthesiology at the University of Ottawa and had served as President and Director of the Cardiac Institute Anaesthetists Partnership for 12 years until ‘passing the torch’ last year.


After receiving his medical degree from Queen’s University in Kingston, Ontario, in 1976, Dr. Cattran completed residencies in Internal Medicine and Anesthesiology, becoming a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) in 1980. He spent a year as a Medical Research Council Research Fellow at the Hospital for Sick Children in Toronto, where he pursued interests in respiratory physiology (helping to develop High Frequency Oscillatory Ventilation) and pediatric cardiac anesthesiology. In 1988, he decided to focus on cardiac anesthesiology and intensive care at the Heart Institute.

Dr. Cattran spent 10 years as Director of the Malignant Hyperthermia Investigations Unit at The Ottawa Hospital and has served on many hospital committees, including the Scientific Research, Research Ethics, and Pharmacy Committees.

In his capacity as lecturer at the University of Ottawa, he has taught in the Core Programs of Anesthesia, Pharmacology and Cardiology.

Research & Clinical Interests 

Currently Dr. Cattran is involved with developing his expertise in transesophageal echocardiography and optimizing ventilatory/clinical strategies in ICU patients with ARDS and Ventilator Induced Lung Injury.



  • Cattran CB, et al: "Oxygenation During High Frequency Ventilation Compared with Conventional Ventilation in two Models of Lung Injury", Anaes and Anal. 61:1982
  • Lewis & Cattran CB, "Malignant Hyperthermia: Choice of Anaesthesia for Muscle Biopsy" - Letter to Can. Anaes. Soc. J., Vol 33, No 3. May 1986
  • Cattran CB. Malignant Hyperthermia and the Dental Practitioner, J. Can Dental Ass. Vol 53, No4, Apr. 1987
  • Allen GC, Cattran CB. Oral Dantrolene Prophylaxis is Effective in Malignant Hyperthermia Patients, Anesthesiology 69:900-904, 1988
  • Cattran CB, et al: Rewarming Following Hypothermic Cardiopulmonary Bypass in the Malignant Hyperthermia Susceptible Patient: Implications for Diagnosis and Perioperative Management, CJA Vol 36, No 1. P81-85, Jan. 1989
  • Nathan HJ, et al: Intravenous Nifedipine to Treat Hypertension After Coronary Artery Revascularization Surgery. A Comparison with Sodium Nitroprusside, Anesth Analg 1992;741-9
  • Dupuis JY, et al: Amrinone and Dobutamine as Primary Treatment of Low Cardiac Output Syndrome Following Coronary Artery Bypass Grafting: A Comparison of their effects on Hemodynamics and Outcome. JCVTA, Vol 6, No 5, p542, Oct 1992.


  • Cattran C, et al: "High Frequency Oscillation and Mean Lung Volume Anesthesiology, Supp. Vol 55, No. 3A, Sept 1981
  • Nathan HJ, Cattran C, et al: "A Continuous Intravenous Nifedipine Infusion for the Control of Hypertension Following Coronary Artery Surgery: Pharmacokinetics and Pharmacodynamics, CASJ Suppl. II, May 1986
  • Allen GC, Cattran CB. Pharmacokinetics of Oral Dantrolene Prophylaxis in Malignant Hyperthermia Susceptible Patients, CJA, 1987;315:835
  • Tough J, Cattran CB. The use of Lidocaine for Femoral Nerve Block in Suspected M.H. Patients, CJA, Vol 35, No 3 (Part II) S121, May 1988
  • Nathan HJ, Cattran CB, et al: The Treatment of Hypertension Following Coronary Artery Surgery: A Comparison of IV Nifedipine and Nitroprusside, CJA Vol 35, No3 (Part II) 568, May 88
  • Dupuis JY, Nathan HJ, Cattran CB, Wynands JE: Amrinone Versus Dobutamine for Treatment of Low Cardiac Output After Coronary Artery Surgery, JCTVA, 1990.
  • Gill IS, Maharaj GS, Cattran C. Emergency Thoracic Aortic Surgery. Accepted for publication and presentation: Birmingham Aortic Surgery Symposium, November 1-2, 1996, Birmingham International Convention Centre - Birmingham, UK.

Share This